Home DailyMed fa20da19-bfce-4d6f-9b18-17707321ce64 National Council for Prescription Drug Programs indexing - billing unit Drug label information. FDA.report displays public Structured Product Labeling data from DailyMed and legacy FDA.report DailyMed cache rows. This page is not medical advice, prescribing advice, or a substitute for the official label reviewed by a qualified healthcare professional. Labeling can change; when a current hydrated DailyMed SPL record is available, FDA.report shows that newer record before legacy cached files.
Manufacturer National Council for Prescription Drug Programs
Effective date 2012-07-24
Label type Indexing - Billing Unit
Version 1
Source full-release
Hydrated at 2026-06-05 03:11:24 Orange Book application contexts# All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book application contexts page 1 of 1 · 1 matching rows.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040784-001 ACETAZOLAMIDE SODIUM ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A040784-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A040784-001 ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL INJECTABLE / INJECTION AP RS 2008-12-10 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.